APO Research
Talk to an analyst

APO RESEARCH · REPORT

Famciclovir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Famciclovir Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchFamciclovir Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Famciclovir Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Famciclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famciclovir Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Famciclovir Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Famciclovir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Famciclovir include Teva, Shandong Luoxin Pharmaceutical Group, Novartis, Mylan, Hainan choitec Pharmaceuticals, Chengdu Diao Pharmaceutical Group, Beijing Jialin Pharmaceutical, Macleods Pharmaceuticals and HISUN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Famciclovir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Famciclovir market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Famciclovir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Famciclovir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Famciclovir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Famciclovir Market by Company

Teva

Shandong Luoxin Pharmaceutical Group

Novartis

Mylan

Hainan choitec Pharmaceuticals

Chengdu Diao Pharmaceutical Group

Beijing Jialin Pharmaceutical

Macleods Pharmaceuticals

HISUN

Hikma

HETERO

Cipla

Aurobindo Pharma

Apotex

Famciclovir Segment by Type

125 mg Tablets

250 mg Tablets

500 mg Tablets

Famciclovir Segment by Application

Cold Sores

Shingles

Genital Herpes

Famciclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famciclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 125 mg Tablets Table 2. Major Company of 250 mg Tablets Table 3. Major Company of 500 mg Tablets Table 4. Global Famciclovir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Famciclovir Sales by Type (2021-2026) & (W Units) Table 6. Global Famciclovir Sales Market Share in Volume by Type (2021-2026) Table 7. Global Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 8. Global Famciclovir Sales Market Share in Value by Type (2021-2026) Table 9. Global Famciclovir Price by Type (2021-2026) & (US$/Unit) Table 10. Global Famciclovir Sales by Type (2027-2032) & (W Units) Table 11. Global Famciclovir Sales Market Share in Volume by Type (2027-2032) Table 12. Global Famciclovir Sales by Type (2027-2032) & (US$ Million) Table 13. Global Famciclovir Sales Market Share in Value by Type (2027-2032) Table 14. Global Famciclovir Price by Type (2027-2032) & (US$/Unit) Table 15. North America Famciclovir Sales by Type (2021-2026) & (W Units) Table 16. North America Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Famciclovir Sales by Type (2021-2026) & (W Units) Table 18. Europe Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Famciclovir Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Famciclovir Sales by Type (2021-2026) & (W Units) Table 22. Latin America Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Famciclovir Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Famciclovir Sales by Type (2021-2026) & (US$ Million) Table 25. Famciclovir Industry Trends Table 26. Famciclovir Industry Drivers Table 27. Famciclovir Industry Opportunities and Challenges Table 28. Famciclovir Industry Restraints Table 29. Global Famciclovir Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Famciclovir Revenue Market Share by Company (2021-2026) Table 31. Global Famciclovir Sales by Company (2021-2026) & (W Units) Table 32. Global Famciclovir Sales Share by Company (2021-2026) Table 33. Global Famciclovir Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Famciclovir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Famciclovir Major Company Production Sites and Headquarters Table 36. Global Famciclovir Company, Product Type & Application Table 37. Global Famciclovir Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Famciclovir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Famciclovir Sales by Region (2021-2026) & (W Units) Table 42. Global Famciclovir Sales Market Share in Volume by Region (2021-2026) Table 43. Global Famciclovir Sales by Region (2021-2026) & (US$ Million) Table 44. Global Famciclovir Sales Market Share in Value by Region (2021-2026) Table 45. Global Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Famciclovir Sales by Region (2027-2032) & (W Units) Table 47. Global Famciclovir Sales Market Share in Volume by Region (2027-2032) Table 48. Global Famciclovir Sales by Region (2027-2032) & (US$ Million) Table 49. Global Famciclovir Sales Market Share in Value by Region (2027-2032) Table 50. Global Famciclovir Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Famciclovir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Famciclovir Sales by Application (2021-2026) & (W Units) Table 53. Global Famciclovir Sales Market Share in Volume by Application (2021-2026) Table 54. Global Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 55. Global Famciclovir Sales Market Share in Value by Application (2021-2026) Table 56. Global Famciclovir Price by Application (2021-2026) & (US$/Unit) Table 57. Global Famciclovir Sales by Application (2027-2032) & (W Units) Table 58. Global Famciclovir Sales Market Share in Volume by Application (2027-2032) Table 59. Global Famciclovir Sales by Application (2027-2032) & (US$ Million) Table 60. Global Famciclovir Sales Market Share in Value by Application (2027-2032) Table 61. Global Famciclovir Price by Application (2027-2032) & (US$/Unit) Table 62. North America Famciclovir Sales by Application (2021-2026) & (W Units) Table 63. North America Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Famciclovir Sales by Application (2021-2026) & (W Units) Table 65. Europe Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Famciclovir Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Famciclovir Sales by Application (2021-2026) & (W Units) Table 69. Latin America Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Famciclovir Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Famciclovir Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Famciclovir Product Portfolio Table 76. Teva Recent Development Table 77. Shandong Luoxin Pharmaceutical Group Company Information Table 78. Shandong Luoxin Pharmaceutical Group Business Overview Table 79. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio Table 81. Shandong Luoxin Pharmaceutical Group Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novartis Famciclovir Product Portfolio Table 86. Novartis Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Famciclovir Product Portfolio Table 91. Mylan Recent Development Table 92. Hainan choitec Pharmaceuticals Company Information Table 93. Hainan choitec Pharmaceuticals Business Overview Table 94. Hainan choitec Pharmaceuticals Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hainan choitec Pharmaceuticals Famciclovir Product Portfolio Table 96. Hainan choitec Pharmaceuticals Recent Development Table 97. Chengdu Diao Pharmaceutical Group Company Information Table 98. Chengdu Diao Pharmaceutical Group Business Overview Table 99. Chengdu Diao Pharmaceutical Group Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio Table 101. Chengdu Diao Pharmaceutical Group Recent Development Table 102. Beijing Jialin Pharmaceutical Company Information Table 103. Beijing Jialin Pharmaceutical Business Overview Table 104. Beijing Jialin Pharmaceutical Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Beijing Jialin Pharmaceutical Famciclovir Product Portfolio Table 106. Beijing Jialin Pharmaceutical Recent Development Table 107. Macleods Pharmaceuticals Company Information Table 108. Macleods Pharmaceuticals Business Overview Table 109. Macleods Pharmaceuticals Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Macleods Pharmaceuticals Famciclovir Product Portfolio Table 111. Macleods Pharmaceuticals Recent Development Table 112. HISUN Company Information Table 113. HISUN Business Overview Table 114. HISUN Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. HISUN Famciclovir Product Portfolio Table 116. HISUN Recent Development Table 117. Hikma Company Information Table 118. Hikma Business Overview Table 119. Hikma Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hikma Famciclovir Product Portfolio Table 121. Hikma Recent Development Table 122. HETERO Company Information Table 123. HETERO Business Overview Table 124. HETERO Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. HETERO Famciclovir Product Portfolio Table 126. HETERO Recent Development Table 127. Cipla Company Information Table 128. Cipla Business Overview Table 129. Cipla Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Cipla Famciclovir Product Portfolio Table 131. Cipla Recent Development Table 132. Aurobindo Pharma Company Information Table 133. Aurobindo Pharma Business Overview Table 134. Aurobindo Pharma Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Aurobindo Pharma Famciclovir Product Portfolio Table 136. Aurobindo Pharma Recent Development Table 137. Apotex Company Information Table 138. Apotex Business Overview Table 139. Apotex Famciclovir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Apotex Famciclovir Product Portfolio Table 141. Apotex Recent Development Table 142. North America Famciclovir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. North America Famciclovir Sales by Country (2021-2026) & (W Units) Table 144. North America Famciclovir Sales Market Share by Country (2021-2026) Table 145. North America Famciclovir Sales Forecast by Country (2027-2032) & (W Units) Table 146. North America Famciclovir Sales Market Share Forecast by Country (2027-2032) Table 147. North America Famciclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Famciclovir Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Famciclovir Market Share by Country (2021-2026) Table 150. North America Famciclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Famciclovir Market Share Forecast by Country (2027-2032) Table 152. Europe Famciclovir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Europe Famciclovir Sales by Country (2021-2026) & (W Units) Table 154. Europe Famciclovir Sales Market Share by Country (2021-2026) Table 155. Europe Famciclovir Sales Forecast by Country (2027-2032) & (W Units) Table 156. Europe Famciclovir Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Famciclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Famciclovir Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Famciclovir Market Share by Country (2021-2026) Table 160. Europe Famciclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Famciclovir Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Famciclovir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Famciclovir Sales by Country (2021-2026) & (W Units) Table 164. Asia-Pacific Famciclovir Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Famciclovir Sales Forecast by Country (2027-2032) & (W Units) Table 166. Asia-Pacific Famciclovir Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Famciclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Famciclovir Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Famciclovir Market Share by Country (2021-2026) Table 170. Asia-Pacific Famciclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Famciclovir Market Share Forecast by Country (2027-2032) Table 172. Latin America Famciclovir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Latin America Famciclovir Sales by Country (2021-2026) & (W Units) Table 174. Latin America Famciclovir Sales Market Share by Country (2021-2026) Table 175. Latin America Famciclovir Sales Forecast by Country (2027-2032) & (W Units) Table 176. Latin America Famciclovir Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Famciclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Famciclovir Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Famciclovir Market Share by Country (2021-2026) Table 180. Latin America Famciclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Famciclovir Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Famciclovir Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Famciclovir Sales by Country (2021-2026) & (W Units) Table 184. Middle East and Africa Famciclovir Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Famciclovir Sales Forecast by Country (2027-2032) & (W Units) Table 186. Middle East and Africa Famciclovir Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Famciclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Famciclovir Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Famciclovir Market Share by Country (2021-2026) Table 190. Middle East and Africa Famciclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Famciclovir Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Famciclovir Distributors List Table 195. Famciclovir Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Famciclovir Image Figure 2. Global Famciclovir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famciclovir Market Size (2021-2032) & (US$ Million) Figure 4. Global Famciclovir Sales (2021-2032) & (W Units) Figure 5. 125 mg Tablets Image Figure 6. Global 125 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 7. 250 mg Tablets Image Figure 8. Global 250 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 9. 500 mg Tablets Image Figure 10. Global 500 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Famciclovir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Famciclovir Market Share by Type 2025 VS 2032 Figure 13. North America Famciclovir Sales Market Share in Volume by Type in 2025 Figure 14. North America Famciclovir Sales Market Share in Value by Type in 2025 Figure 15. Europe Famciclovir Sales Market Share in Volume by Type in 2025 Figure 16. Europe Famciclovir Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Famciclovir Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Famciclovir Sales Market Share in Value by Type in 2025 Figure 19. Latin America Famciclovir Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Famciclovir Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Famciclovir Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Famciclovir Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cold Sores Image Figure 26. Global Cold Sores Sales YoY Growth (2021-2032) & (W Units) Figure 27. Shingles Image Figure 28. Global Shingles Sales YoY Growth (2021-2032) & (W Units) Figure 29. Genital Herpes Image Figure 30. Global Genital Herpes Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Famciclovir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Famciclovir Market Share by Application 2025 VS 2032 Figure 33. North America Famciclovir Sales Market Share in Volume by Application in 2025 Figure 34. North America Famciclovir Sales Market Share in Value by Application in 2025 Figure 35. Europe Famciclovir Sales Market Share in Volume by Application in 2025 Figure 36. Europe Famciclovir Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Famciclovir Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Famciclovir Sales Market Share in Value by Application in 2025 Figure 39. Latin America Famciclovir Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Famciclovir Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Famciclovir Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Famciclovir Sales Market Share in Value by Application in 2025 Figure 43. North America Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Famciclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Famciclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Famciclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Famciclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Famciclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Famciclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Famciclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Famciclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Famciclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Famciclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Famciclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Famciclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Famciclovir Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Famciclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Famciclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Famciclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Famciclovir Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Famciclovir Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 125 mg Tablets
  • 250 mg Tablets
  • 500 mg Tablets
Applications
  • Cold Sores
  • Shingles
  • Genital Herpes
Companies covered
  • Teva
  • Shandong Luoxin Pharmaceutical Group
  • Novartis
  • Mylan
  • Hainan choitec Pharmaceuticals
  • Chengdu Diao Pharmaceutical Group
  • Beijing Jialin Pharmaceutical
  • Macleods Pharmaceuticals
  • HISUN
  • Hikma
  • HETERO
  • Cipla
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Famciclovir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Famciclovir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Famciclovir Market by Type
  6. 1.3.1 125 mg Tablets
  7. 1.3.2 250 mg Tablets
  8. 1.3.3 500 mg Tablets
  9. 1.4 Global Famciclovir Market Size by Type
  10. 1.4.1 Global Famciclovir Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Famciclovir Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Famciclovir Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Famciclovir Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Famciclovir Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Famciclovir Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Famciclovir Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Famciclovir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Famciclovir Industry Trends
  2. 2.2 Famciclovir Industry Drivers
  3. 2.3 Famciclovir Industry Opportunities and Challenges
  4. 2.4 Famciclovir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Famciclovir Revenue (2021-2026)
  2. 3.2 Global Top Players by Famciclovir Sales (2021-2026)
  3. 3.3 Global Top Players by Famciclovir Price (2021-2026)
  4. 3.4 Global Famciclovir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Famciclovir Major Company Production Sites & Headquarters
  6. 3.6 Global Famciclovir Company, Product Type & Application
  7. 3.7 Global Famciclovir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Famciclovir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Famciclovir Tier 1, Tier 2, and Tier 3
4 Famciclovir Regional Status and Outlook
  1. 4.1 Global Famciclovir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Famciclovir Historic Market Size by Region
  3. 4.2.1 Global Famciclovir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Famciclovir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Famciclovir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Famciclovir Forecasted Market Size by Region
  7. 4.3.1 Global Famciclovir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Famciclovir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Famciclovir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Famciclovir by Application
  1. 5.1 Famciclovir Market by Application
  2. 5.1.1 Cold Sores
  3. 5.1.2 Shingles
  4. 5.1.3 Genital Herpes
  5. 5.2 Global Famciclovir Market Size by Application
  6. 5.2.1 Global Famciclovir Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Famciclovir Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Famciclovir Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Famciclovir Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Famciclovir Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Famciclovir Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Famciclovir Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Famciclovir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Famciclovir Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Shandong Luoxin Pharmaceutical Group
  8. 6.2.1 Shandong Luoxin Pharmaceutical Group Company Information
  9. 6.2.2 Shandong Luoxin Pharmaceutical Group Business Overview
  10. 6.2.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
  12. 6.2.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Famciclovir Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Famciclovir Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Hainan choitec Pharmaceuticals
  26. 6.5.1 Hainan choitec Pharmaceuticals Company Information
  27. 6.5.2 Hainan choitec Pharmaceuticals Business Overview
  28. 6.5.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
  30. 6.5.5 Hainan choitec Pharmaceuticals Recent Developments
  31. 6.6 Chengdu Diao Pharmaceutical Group
  32. 6.6.1 Chengdu Diao Pharmaceutical Group Company Information
  33. 6.6.2 Chengdu Diao Pharmaceutical Group Business Overview
  34. 6.6.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
  36. 6.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
  37. 6.7 Beijing Jialin Pharmaceutical
  38. 6.7.1 Beijing Jialin Pharmaceutical Company Information
  39. 6.7.2 Beijing Jialin Pharmaceutical Business Overview
  40. 6.7.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
  42. 6.7.5 Beijing Jialin Pharmaceutical Recent Developments
  43. 6.8 Macleods Pharmaceuticals
  44. 6.8.1 Macleods Pharmaceuticals Company Information
  45. 6.8.2 Macleods Pharmaceuticals Business Overview
  46. 6.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
  48. 6.8.5 Macleods Pharmaceuticals Recent Developments
  49. 6.9 HISUN
  50. 6.9.1 HISUN Company Information
  51. 6.9.2 HISUN Business Overview
  52. 6.9.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 HISUN Famciclovir Product Portfolio
  54. 6.9.5 HISUN Recent Developments
  55. 6.10 Hikma
  56. 6.10.1 Hikma Company Information
  57. 6.10.2 Hikma Business Overview
  58. 6.10.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hikma Famciclovir Product Portfolio
  60. 6.10.5 Hikma Recent Developments
  61. 6.11 HETERO
  62. 6.11.1 HETERO Company Information
  63. 6.11.2 HETERO Business Overview
  64. 6.11.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HETERO Famciclovir Product Portfolio
  66. 6.11.5 HETERO Recent Developments
  67. 6.12 Cipla
  68. 6.12.1 Cipla Company Information
  69. 6.12.2 Cipla Business Overview
  70. 6.12.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cipla Famciclovir Product Portfolio
  72. 6.12.5 Cipla Recent Developments
  73. 6.13 Aurobindo Pharma
  74. 6.13.1 Aurobindo Pharma Company Information
  75. 6.13.2 Aurobindo Pharma Business Overview
  76. 6.13.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Aurobindo Pharma Famciclovir Product Portfolio
  78. 6.13.5 Aurobindo Pharma Recent Developments
  79. 6.14 Apotex
  80. 6.14.1 Apotex Company Information
  81. 6.14.2 Apotex Business Overview
  82. 6.14.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Apotex Famciclovir Product Portfolio
  84. 6.14.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Famciclovir Sales by Country
  2. 7.1.1 North America Famciclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Famciclovir Sales by Country (2021-2026)
  4. 7.1.3 North America Famciclovir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Famciclovir Market Size by Country
  6. 7.2.1 North America Famciclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Famciclovir Market Size by Country (2021-2026)
  8. 7.2.3 North America Famciclovir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Famciclovir Sales by Country
  2. 8.1.1 Europe Famciclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Famciclovir Sales by Country (2021-2026)
  4. 8.1.3 Europe Famciclovir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Famciclovir Market Size by Country
  6. 8.2.1 Europe Famciclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Famciclovir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Famciclovir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Famciclovir Sales by Country
  2. 9.1.1 Asia-Pacific Famciclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Famciclovir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Famciclovir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Famciclovir Market Size by Country
  6. 9.2.1 Asia-Pacific Famciclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Famciclovir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Famciclovir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Famciclovir Sales by Country
  2. 10.1.1 South America Famciclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Famciclovir Sales by Country (2021-2026)
  4. 10.1.3 South America Famciclovir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Famciclovir Market Size by Country
  6. 10.2.1 South America Famciclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Famciclovir Market Size by Country (2021-2026)
  8. 10.2.3 South America Famciclovir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Famciclovir Sales by Country
  2. 11.1.1 Middle East and Africa Famciclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Famciclovir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Famciclovir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Famciclovir Market Size by Country
  6. 11.2.1 Middle East and Africa Famciclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Famciclovir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Famciclovir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Famciclovir Value Chain Analysis
  2. 12.1.1 Famciclovir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Famciclovir Production Mode & Process
  7. 12.2 Famciclovir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Famciclovir Distributors
  10. 12.2.3 Famciclovir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst